Health Costs

  • Your Selections:

Refine Results

date

Topics

Content Type

Tags

Five Things to Know about the Renewal of Extra Affordable Care Act Subsidies in the Inflation Reduction Act

As part of the Inflation Reduction Act, the Senate recently passed a three-year extension (through 2025) of enhanced subsidies for people buying their own health coverage on the Affordable Care Act Marketplaces. The enhanced subsidies increase the amount of financial help available to those already eligible and also newly expand subsidies to middle-income people, many of whom were previously priced out of coverage. Here’s what to know about the likely renewal of these subsidies:

Blog Read More

August 11 Web Event: Understanding the Health Care Provisions in the Inflation Reduction Act

The Inflation Reduction Act includes several landmark health care provisions that would lower prescription drug costs for people with Medicare, reduce Medicare drug spending and extend enhanced subsidies for Affordable Care Act marketplace coverage. On Thursday, August 11, a panel of KFF experts held a web briefing to explain these…

Event Read More

What Impact Has the Coronavirus Pandemic Had on Health Care Employment?

This chart collection takes a deep dive into employment data  to analyze how jobs and wages in the health sector shrank and recovered during the coronavirus pandemic.

Issue Brief Read More

Spending on Medicare Advantage Quality Bonus Program Payment Reached $10 Billion in 2022

Federal spending on Medicare Advantage bonus payments will reach at least $10 billion in 2022, as the majority of Medicare Advantage enrollees are in plans that are receiving bonus payments. The average bonus payment per enrollee is highest for Medicare beneficiaries in employer sponsored plans and lowest for those enrolled in special needs plans.

Issue Brief Read More

How Might Current Federal Drug Pricing Proposals Impact Medicaid?

Although attention in current federal actions is largely focused on Medicare and private insurance drug prices, federal legislation also has been recently introduced or enacted that would affect Medicaid prescription drug policy.

Blog Read More

KFF Health Tracking Poll – May 2021: Prescription Drug Prices Top Public’s Health Care Priorities

The latest KFF Health Tracking Poll explores the public’s views on the U.S. role in distributing COVID vaccines to other countries, health care priorities for Congress, prescription drug regulations and price negotiations, and affordability changes in the COVID-19 relief bill.

Poll Finding Read More

FDA’s Approval of Biogen’s New Alzheimer’s Drug Has Huge Cost Implications for Medicare and Beneficiaries

The question of what would happen when a new, expensive prescription drug comes to market for a disease like Alzheimer’s that afflicts millions of people has loomed large in discussions over drug prices in the U.S. This brief analyzes the cost implications for Medicare and beneficiaries associated with Biogen’s new FDA-approved Alzheimer’s drug, which will cost $56,000 per year.

Issue Brief Read More

Why Drug Price Negotiation Has Staying Power

In this Axios column, Drew Altman looks beyond Medicare to what’s at stake for employers and workers in the debate about the government negotiating drug prices.

Perspective Read More

Most private insurers are no longer waiving cost-sharing for COVID-19 treatment

This analysis finds nearly three quarters of the largest health plans in each state are no longer waiving enrollees’ cost-sharing requirements for COVID-19 treatment as of August 2021. Insurers largely waived those costs early in the pandemic, before safe and effetive vaccines were available.

Issue Brief Read More

Health Insurer Financial Performance Through September 2020

In this brief, we analyze third quarter data from 2018 to 2020 to examine how insurance markets performed financially through the end of September. Average margins remained relatively high compared to the same point in recent years, suggesting many insurers remained profitable even as non-COVID-related care returned in the summer and fall.

Issue Brief Read More

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.